Total returns on $10,000

Objective
The investment seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) the daily performance of the Dow Jones U.S. Health CareSM Index.
The fund invests in securities and derivatives that the adviser believes, in combination, should have similar daily return characteristics as one and one-half times (1.5x) the daily return of the index. The index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.
Profile
| Fund type | Open Ended Investment Company |
|---|---|
| Investment style (stocks) | Market Cap: LargeInvestment Style: Blend |
| Morningstar category | Health |
| Launch date | 19/06/2000 |
| Price currency | USD |
| Domicile | United States |
| Symbol | HCPIX |
| Manager & start date | Hratch Najarian 01/10/2011 |
Investment
| Pricing frequency | Daily |
|---|---|
| Total net assets | 12.91m USDAs of Mar 31 2013 |
| Net expense ratio | 1.78% |
| Front end load | -- |
| Deferred load | -- |
| Redemption fee | -- |
| Min. initial investment | 15,000 USD |
| Min. additional investment | -- |
| Initial IRA | 15,000 USD |
| Additional IRA | -- |
| Available for sale | Puerto Rico, United States |
Diversification
Asset type

US stock | 67.27% |
|---|---|
Cash | 31.52% |
Other | 1.11% |
Non-US stock | 0.10% |
Bond | 0.00% |
Top 5 sectors
Top 5 Regions
United States | 67.27% |
|---|---|
Eurozone | 0.10% |
Top 5 holdings
| Company | IC View | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|---|
| Johnson & Johnson JNJ:NYQ | +39.97% | 7.85% | ||
| Pfizer Inc PFE:NYQ | +32.48% | 7.70% | ||
| Merck & Co Inc MRK:NYQ | +27.54% | 5.04% | ||
| Amgen Inc AMGN:NSQ | +52.01% | 2.53% | ||
| Gilead Sciences Inc GILD:NSQ | +125.00% | 2.28% |
